Hypocretin and melanin-concentrating hormone in patients with Huntington disease (Q45289637)

11 December 2017

title

Hypocretin and melanin-concentrating hormone in patients with Huntington disease (English)

1 reference

11 December 2017

0 references

1 reference

11 December 2017

Dick Swaab

0 references

Sebastiaan Overeem

1 reference

11 December 2017

Raymund Roos

1 reference

11 December 2017

Ahmad Aziz

1 reference

11 December 2017

Marion Maat-Schieman

1 reference

11 December 2017

Unga Unmehopa

1 reference

11 December 2017

Freek Roelandse

1 reference

11 December 2017

Sjoerd van Duinen

1 reference

11 December 2017

Gert-Jan Lammers

1 reference

11 December 2017

publication date

22 May 2008

1 reference

11 December 2017

1 reference

11 December 2017

1 reference

11 December 2017

1 reference

11 December 2017

page(s)

474-483

1 reference

Hypocretin/orexin-containing neurons are produced in one sharp peak in the developing ventral diencephalon.

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Hypocretin-1 (orexin A) levels are normal in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Orexin and psychiatric symptoms in suicide attempters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Orexin A-like immunoreactivity in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Hypocretin (orexin) loss in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Relationship between CSF hypocretin levels and hypocretin neuronal loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Hypothalamic growth hormone-releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader-Willi syndrome or obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Interacting appetite-regulating pathways in the hypothalamic regulation of body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Excitotoxic degeneration of hypothalamic orexin neurons in slice culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Mouse models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Orexin loss in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Expanding the scales: The multiple roles of MCH in regulating energy balance and other biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Mice lacking melanin-concentrating hormone are hypophagic and lean

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Comparison of melanin-concentrating hormone and hypocretin/orexin mRNA expression patterns in a new parceling scheme of the lateral hypothalamic zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Hypocretin (orexin) cell loss in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Increased metabolism in the R6/2 mouse model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Press-blotting on gelatin-coated nitrocellulose membranes. A method for sensitive quantitative immunodetection of peptides after gel isoelectric focusing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

Nocturnal sleep in huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

To eat or to sleep? Orexin in the regulation of feeding and wakefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00135.X

10.1111/J.1750-3639.2008.00135.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference